Oncometabolite succinate promotes angiogenesis by upregulating VEGF expression through GPR91-mediated STAT3 and ERK activation

Mu, Xianmin, Zhao, Ting, Xu, Che, Shi, Wei, Geng, Biao, Shen, Jiajia, Zhang, Chen, Pan, Jinshun +5 more·2017·Oncotarget
DOI 10.18632/oncotarget.14485

Cited by (125)

Items 101–125 of 125

  1. Genetic and Molecular Differences in Head and Neck Cancer Based on Smoking History
    Rong Jiang, May Z. Gao, Meng Chen, Darien J. Weatherspoon, Tammara L. Watts, Nosayaba Osazuwa‐Peters · 2025 · JAMA Otolaryngology–Head & Neck Surgery
  2. Prostate Cancer-Induced Changes in Urinary Odors at Biomarker Concentrations of PPQ with Validation by Sniffer Mouse Behavioural Assays
    Takaaki Sato, Takaaki Sato, M Nonomura, 公彦 米田, Sho Mizutani, Yoichi Mizutani · 2021
  3. The crosstalk between epigenetics and metabolism in the malignant cell
    Adrian Bogdan Țigu, Andrei Ivancuta, Catalin Sorin Constantinescu, Vlad Moisoiu, Olga Grăjdieru, Ciprian Cucoreanu, Mădălina Nistor, Dávid Kegyes, Anamaria Bancos, Victor Tomacinschii et al. · 2026 · Discover Oncology
  4. Mitochondria: from powerhouses of cells to hubs in antitumor immunity
    Xiaofeng Li, Yanfeng Shi, Yan Zhao, Gengjun Zhu, Lifang Jin · 2026 · Frontiers in Immunology
  5. Connection between Warburg Effect and Oncometabolites Biosynthesis with its Clinical Implications
    Wojciech Szlasa · 2020 · Organic and Medicinal Chemistry International Journal
  6. Got Oxygen? Studies on Mesenchymal Cell Hypoxia Inducible Factor-1α in Lung Development
    Reece P. Stevens, Ji Lee, Natalie Norwood Bauer, Troy Stevens · 2023 · American Journal of Respiratory Cell and Molecular Biology
  7. TGF-β Suppressed Succinat Dehydrogenase to Promote Osteosarcoma Chemo-Resistance Through An HIF1α Dependent Manner
    Yangbo Xu, Yafei Li, Feifan Xiang, Yong Deng, Zhong Li, Yunkang Yang, Daiqing Wei · 2021 · Research Square
  8. Rôle de la succinate déshydrogénase dans le cancer
    Sophie Moog, Judith Favier · 2022 · médecine/sciences
  9. Major heritable renal cell carcinoma syndromes: novel treatment options and future perspectives
    Vishen Naidoo, Marlon Perera, Ahmed Adam · 2022 · Current Opinion in Urology
  10. Succinate as an Oncometabolite in Endocrine, Mesenchymal, and Epithelial Tumors
    Seyed Amir Miratashi Yazdi, Elham Nazar · 2022 · Iranian Red Crescent Medical Journal
  11. Commentary: Why have different key biomarkers been reported in the same types of samples from patients with identical diseases?
    Takaaki Sato, Yasuhiko Takahashi, Yoichi Mizutani · 2023 · URINE
  12. Oncometabolites in tumor cells: Current technique and procedure
    Seema Nayak, Anupam Kumar Sriwastava · 2024 · Elsevier eBooks
  13. Additional file 3 of Effect and potential mechanism of oncometabolite succinate promotes distant metastasis of colorectal cancer by activating STAT3
    Yu, Jiangnan, Yang, Hong, Lin Zhang, Suye Ran, Qing Shi, Peng, Pailan, Liu, Qi, Lingyu Song · 2024 · Figshare
  14. Additional file 1 of Effect and potential mechanism of oncometabolite succinate promotes distant metastasis of colorectal cancer by activating STAT3
    Yu, Jiangnan, Yang, Hong, Lin Zhang, Suye Ran, Qing Shi, Peng, Pailan, Liu, Qi, Lingyu Song · 2024 · Figshare
  15. Additional file 2 of Effect and potential mechanism of oncometabolite succinate promotes distant metastasis of colorectal cancer by activating STAT3
    Yu, Jiangnan, Yang, Hong, Lin Zhang, Suye Ran, Shi, Qing, Peng, Pailan, Liu, Qi, Lingyu Song · 2024 · Figshare
  16. Targeting succinate-driven microglial metabolic reprogramming alleviates neuroinflammation after cerebral ischemia–reperfusion
    Zhuohang Liu, Zengyu Zhang, Kaicheng Yang, Rong Ji, Xueyu Mao, Huicong Niu, Min Chu, Yong Wang, Jing Zhao · 2026 · Research Square
  17. Imagerie des dysfonctions vasculaires : développement d'un agent d'imagerie TEP marqué au gallium 68 permettant l'évaluation in vivo de l'expression de l'angiomotine
    Anaïs Moyon · 2021
  18. Clinically significant molecular alterations of mitochondria in carcinogenesis and age-related diseases: Part 2. Exposome influences, biomarkers and therapeutic strategies
    G. V. Gerashchenko, M. A. Tukalo · 2026 · Biopolymers and Cell
  19. Copper Promotes Breast Cancer through Immunometabolic Reprogramming: A Multi-omics Mediation Analysis
    Ning Wang, Chen Suo, Wei Yan, Jing Zheng, Baokun Cao, Ziyu Yuan, Weimin Ye, Fang Fang, Xingdong Chen · 2026 · Cancer Epidemiology Biomarkers & Prevention
  20. Succinate as a metabolic–signaling dual-function hub in skeletal muscle: linking exercise adaptation to myopathic dysfunction
    Juncheng Si, Haodong Tian, Mingjie Guo, Yongxia Lin, Yongshan Gong, Yang Wang, Li Peng · 2026 · Molecular Biology Reports
  21. Dual-BINN: a dual-branch biologically informed neural network integrating Reactome pathways and ClassyFire structures for metabolomics
    Longwei Guo, Xinyu Wang, Sensen Liu, Changhao Xu, Kecheng Yang · 2026 · Exploration of Drug Science
  22. Metabolic Bottlenecks and Opportunities: Reshaping the Tumor Microenvironment for Cancer Immunotherapy
    Jianing Zhang, Zimei Tang, Yiran Wang, Jiaying Wan, Yajing Zhou, Jiexiao Li, Jie Ming · 2026 · Cells
  23. Sucnr1 Mediates Leukocyte–Endothelial Cell Interactions Induced by Tnfα
    Sandra Coll, Ana Crespo Jarén, C Bauset, Dulce C. Macias-Ceja, D Ortiz‐Masiá, Jesús Cosín‐Roger, Maria Dolores Barrachina, Sara Calatayud · 2026 · International Journal of Molecular Sciences
  24. BindingDB Entry 50019545: Development and Characterization of Potent Succinate Receptor Fluorescent Tracers.
    BindingDB · 2024 · UC San Diego
  25. Evolution of vascular normalization strategies: from anti-angiogenesis to remodeling the tumor microenvironment
    Qian Huang, Yujing Guo, Sha Yin, Lunbiao Gan, Zehua Liu, Wenxiu Ru, Yu Lu, Sijia Di, Fengze Nie, Siyu Yao et al. · 2026 · Frontiers in Immunology